0001752724-24-022182.txt : 20240213 0001752724-24-022182.hdr.sgml : 20240213 20240213084733 ACCESSION NUMBER: 0001752724-24-022182 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231130 FILED AS OF DATE: 20240213 DATE AS OF CHANGE: 20240213 EFFECTIVENESS DATE: 20240213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD NEW YORK TAX-FREE FUNDS CENTRAL INDEX KEY: 0000788599 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-04570 FILM NUMBER: 24622788 BUSINESS ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: PO BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD NEW YORK INSURED TAX FREE FUND DATE OF NAME CHANGE: 19920703 0000788599 S000002905 Vanguard New York Long-Term Tax-Exempt Fund C000007969 Investor Shares VNYTX C000007970 Admiral Shares VNYUX 0000788599 S000002906 Vanguard New York Municipal Money Market Fund C000007971 Investor Shares VYFXX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000788599 XXXXXXXX 811-04570 true false false N-1A true VANGUARD NEW YORK TAX-FREE FUNDS 811-04570 0000788599 549300IVPEPO12W2EL28 100 VANGUARD BOULEVARD MALVERN 19355 US-PA US 6106691000 State Street Bank and Trust One Congress Street, Suite 1 Boston 20114 617-662-3839 The accounts, books, and other documents required to be maintained by Registrant pursuant to section 31(a) of the Investment Company Act of 1940 and the Rules thereunder. N N N-1A 2 Y David Thomas N/A N Mortimer J. Buckley 002167630 Y Andre F. Perold N/A N Deanna Mulligan N/A N Grant Reid N/A N Peter F. Volanakis N/A N Mark Loughridge N/A N Emerson U. Fullwood N/A N Sarah Bloom Raskin N/A N Tara Bunch N/A N F. Joseph Loughrey N/A N Scott C. Malpass N/A N Jacqueline Angell 005606776 100 Vanguard Boulevard Malvern 19355 XXXXXX N N N N N N VANGUARD MARKETING CORP. 8-21570 000007452 N/A Y N PRICEWATERHOUSECOOPERS LLP 000000238 5493002GVO7EO8RNNS37 N N N N N N N VANGUARD NEW YORK LONG-TERM TAX-EXEMPT FUND S000002905 9X54UMZHJBMD08GNDG54 N 2 0 0 N/A Y N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(f)(17 CFR 270.18f-4(f)) Rule 17a-7 (17 CFR 270.17a-7) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) N N N N The Vanguard Group, Inc. 801-11953 000105958 5493002789CX3L0CJP65 N The Vanguard Group, Inc. 084-00772 5493002789CX3L0CJP65 Y N N Markit North America INC 13-4153988 TIN N Markit Group Limited 549300HLPTRASHS0E726 GB N ICE Data Pricing and Reference Data LLC 13-36687789 TIN N JPMorgan Chase Bank 7H6GLXDRUGQFU57RNE97 N Bloomberg Finance LP 5493001KJTIIGC8Y1R12 N Refinitiv US LLC 20-4530702 TIN N ITG Analytics Inc 41-2190282 TIN N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Vanguard Group, Inc. 5493002789CX3L0CJP65 Y N N STATE STREET BANK AND TRUST 571474TGEMMWANRLN572 N Y THE VANGUARD GROUP, INC. 5493002789CX3L0CJP65 Y N N 0.00000000 Wells Fargo Securities, LLC 008-22947 000007665 VYVVCKR63DVZZN70PB21 328222464.34999990 Barclays Capital Inc. 008-41342 000019714 AC28XWWI3WIBK2824319 1645086252.67000010 BofA Securities, Inc. 008-69787 000283942 549300HN4UKV1E2R3U73 751928243.80999982 U.S. Bancorp 008-35359 000017868 N1GZ7BBF3NP8GI976H15 521970000.00000000 Morgan Stanley & Co. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 393196095.04000002 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 1501207935.01999990 TD Securities (USA) LLC 008-36747 000018476 SUVUFHICNZMP2WKHG940 255886580.55000001 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 377508369.45999998 UBS Securities LLC 008-22651 000007654 T6FIZBDPKLYJKFCRVK44 444552470.94999999 Jefferies LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 494854953.90999997 8133758875.82999960 N 4265864747.61833333 Committed 4300000000.00000000 N N N N VANGUARD NEW YORK MUNICIPAL MONEY MARKET FUND S000002906 G4528JUXYSF6QL6F4092 N 1 0 0 Money Market Fund Y N N N N/A N/A N/A Rule 18f-4(f)(17 CFR 270.18f-4(f)) Rule 32a-4 (17 CFR 270.32a-4) Rule 17a-7 (17 CFR 270.17a-7) Y N N N The Vanguard Group, Inc. 801-11953 000105958 5493002789CX3L0CJP65 N The Vanguard Group, Inc. 084-00772 5493002789CX3L0CJP65 Y N N Markit North America INC 13-4153988 TIN N ICE Data Pricing and Reference Data LLC 13-36687789 TIN N Refinitiv US LLC 20-4530702 TIN N ITG Analytics Inc 41-2190282 TIN N Bloomberg Finance LP 5493001KJTIIGC8Y1R12 N Markit Group Limited 549300HLPTRASHS0E726 GB N JPMorgan Chase Bank 7H6GLXDRUGQFU57RNE97 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Vanguard Group, Inc. 5493002789CX3L0CJP65 Y N N STATE STREET BANK AND TRUST 571474TGEMMWANRLN572 N Y THE VANGUARD GROUP, INC. 5493002789CX3L0CJP65 Y N N 0.00000000 Piper Sandler & Co. 008-15204 000000665 549300GRQCWQ3XGH0H10 171260000.00000000 RBC Capital Markets, LLC 008-45411 000031194 549300LCO2FLSSVFFR64 205045000.00000000 Morgan Stanley & Co. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 424250000.00000000 TD Securities (USA) LLC 008-36747 000018476 SUVUFHICNZMP2WKHG940 333575000.00000000 U.S. Bancorp 008-35359 000017868 N1GZ7BBF3NP8GI976H15 626815000.00000000 CITIGROUP INC. N/A N/A 6SHGI4ZSSLCXXQSBB395 304340000.00000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 1326638561.76000000 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 310007000.00000000 Jefferies LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 245630000.00000000 BofA Securities, Inc. 008-69787 000283942 549300HN4UKV1E2R3U73 827694000.00000000 5453256578.26000000 N 2591096949.29824701 Committed 4300000000.00000000 N N N true INTERNAL CONTROL RPT 2 newyorktaxfreefunds11.30.txt Report of Independent Registered Public Accounting Firm To the Board of Trustees of Vanguard New York Tax-Free Funds and Shareholders of Vanguard New York Long-Term Tax-Exempt Fund and Vanguard New York Municipal Money Market Fund In planning and performing our audits of the financial statements of Vanguard New York Long-Term Tax- Exempt Fund and Vanguard New York Municipal Money Market Fund (constituting Vanguard New York Tax-Free Funds, hereafter collectively referred to as the "Funds") as of and for the year ended November 30, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Funds' internal control over financial reporting. The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of November 30, 2023. This report is intended solely for the information and use of the Board of Trustees of Vanguard New York Tax-Free Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/PricewaterhouseCoopers LLP Philadelphia, Pennsylvania January 19, 2024 1